BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25636478)

  • 1. Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.
    Maione F; Giraudo E
    Methods Mol Biol; 2015; 1267():349-65. PubMed ID: 25636478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma.
    Liu P; Zhang C; Chen J; Zhang R; Ren J; Huang Y; Zhu F; Li Z; Wu G
    J Immunother; 2011 Apr; 34(3):320-6. PubMed ID: 21389866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies.
    Chen P; Bonaldo P
    Int Rev Cell Mol Biol; 2013; 301():1-35. PubMed ID: 23317816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.
    Leuci V; Maione F; Rotolo R; Giraudo E; Sassi F; Migliardi G; Todorovic M; Gammaitoni L; Mesiano G; Giraudo L; Luraghi P; Leone F; Bussolino F; Grignani G; Aglietta M; Trusolino L; Bertotti A; Sangiolo D
    J Transl Med; 2016 May; 14(1):119. PubMed ID: 27149858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of the vasculature for treatment of cancer and other diseases.
    Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
    Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy.
    Gee MS; Procopio WN; Makonnen S; Feldman MD; Yeilding NM; Lee WM
    Am J Pathol; 2003 Jan; 162(1):183-93. PubMed ID: 12507901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels.
    Sawada J; Urakami T; Li F; Urakami A; Zhu W; Fukuda M; Li DY; Ruoslahti E; Komatsu M
    Cancer Cell; 2012 Aug; 22(2):235-49. PubMed ID: 22897853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound.
    Ho YJ; Chu SW; Liao EC; Fan CH; Chan HL; Wei KC; Yeh CK
    Theranostics; 2019; 9(24):7370-7383. PubMed ID: 31695774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of wall compliance and permeability on blood-flow rate in counter-current microvessels formed from anastomosis during tumor-induced angiogenesis.
    Guo P; Fu BM
    J Biomech Eng; 2012 Apr; 134(4):041003. PubMed ID: 22667678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
    Majidpoor J; Mortezaee K
    Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood vessel normalization in the hamster oral cancer model for experimental cancer therapy studies.
    Molinari AJ; Aromando RF; Itoiz ME; Garabalino MA; Monti Hughes A; Heber EM; Pozzi EC; Nigg DW; Trivillin VA; Schwint AE
    Anticancer Res; 2012 Jul; 32(7):2703-9. PubMed ID: 22753729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming.
    Tian L; Goldstein A; Wang H; Ching Lo H; Sun Kim I; Welte T; Sheng K; Dobrolecki LE; Zhang X; Putluri N; Phung TL; Mani SA; Stossi F; Sreekumar A; Mancini MA; Decker WK; Zong C; Lewis MT; Zhang XH
    Nature; 2017 Apr; 544(7649):250-254. PubMed ID: 28371798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of pericyte α6β1-integrin in tumour blood vessels.
    Reynolds LE; D'Amico G; Lechertier T; Papachristodoulou A; Muñoz-Félix JM; De Arcangelis A; Baker M; Serrels B; Hodivala-Dilke KM
    J Cell Sci; 2017 May; 130(9):1583-1595. PubMed ID: 28289267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.
    Shen Y; Li S; Wang X; Wang M; Tian Q; Yang J; Wang J; Wang B; Liu P; Yang J
    J Exp Clin Cancer Res; 2019 Oct; 38(1):427. PubMed ID: 31656203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular remodeling in cancer.
    Farnsworth RH; Lackmann M; Achen MG; Stacker SA
    Oncogene; 2014 Jul; 33(27):3496-505. PubMed ID: 23912450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic therapy: creating a unique "window" of opportunity.
    Lin MI; Sessa WC
    Cancer Cell; 2004 Dec; 6(6):529-31. PubMed ID: 15607955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in wound healing and tumor metastasis.
    Ruiter DJ; Schlingemann RO; Westphal JR; Denijn M; Rietveld FJ; De Waal RM
    Behring Inst Mitt; 1993 Aug; (92):258-72. PubMed ID: 7504453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericyte-coverage of human tumor vasculature and nanoparticle permeability.
    Zhang L; Nishihara H; Kano MR
    Biol Pharm Bull; 2012; 35(5):761-6. PubMed ID: 22687413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.